Group One Trading, L.P. Bio N Tech Se Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Bio N Tech Se stock. As of the latest transaction made, Group One Trading, L.P. holds 63,304 shares of BNTX stock, worth $6.65 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
63,304
Previous 66,072
4.19%
Holding current value
$6.65 Million
Previous $7.53 Million
23.43%
% of portfolio
0.26%
Previous 0.28%
Shares
20 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$857 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$447 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$425 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$199 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$190 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...